FDA import alert status
Cipla Limited
India · appears on 2 FDA import alerts
2
Red-list alerts
0
Green-list alerts
India
Country
10/09/2013
Last entry seen
What this means
As published on the official FDA import alert list, this firm appears on 2 red lists. A red-list firm is subject to Detention Without Physical Examination (DWPE): FDA can detain its shipments at the border automatically, without sampling. The burden shifts to the importer to prove the goods are not violative.
Import alert status changes over time. Import Alert Radar re-checks the official FDA source every day; the entries below reflect the latest refresh (2026-07-21 UTC).
Do you buy from Cipla Limited?
Put this supplier on watch: we re-check the official FDA import alert list daily and email you the day Cipla Limited is added to a red list — or removed from one — so a detained shipment never catches you by surprise.
Red-list entries
- Import Alert 66-57RED · 09/10/2009
Detention Without Physical Examination of Foreign Manufactured Unapproved Prescription Drugs Distributed to Individuals in the U.S.
- Import Alert 66-66RED · 10/09/2013
APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122
Is Cipla Limited in your supply chain? Watch your suppliers from $19/mo →